Skip to content

Premature Ovarian Failure (Genetic and Physiopathologic Analysis)

Premature Ovarian Failure : Genetic and Physiopathologic Analysis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00780897
Acronym
GéNIOP
Enrollment
87
Registered
2008-10-28
Start date
2005-03-31
Completion date
2009-03-31
Last updated
2008-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ovarian Failure

Keywords

PREMATURE OVARIAN FAILURE (POF), GENETIC ANALYSIS, PHYSIOPATHOLOGIC ANALYSIS

Brief summary

Premature Ovarian Failure (POF), syndrome observed in young woman, present consequences on hormonal and leads at definitive infertility. It's a rare and complex syndrome and for this reason, we propose to initiate a collaborative team network to understand better his genetic and physiopathology. We are going to realize a global study of this syndrome with clinical and fundamentals approaches. We wish that this project allows us to understand better the physiopathology of this rare disease. Finally, POF responsible genes identification is the base for future development of therapeutics approaches.

Detailed description

Premature ovarian failure (POF) is a rare but not exceptional disease concerning 0.1% of the more-than-thirty-years-old women. On the clinical aspect, patients present a primary or secondary amenorrhea depending on when the disease occurs in their lives. Infertility is most of the time definitive and the yet only available therapy is auto implantation of cryopreserved oocytes. Initiation of a substitutive hormonal treatment is also necessary to prevent the consequences of estrogenic hardship (i.e leading to osteoporosis). POF has numerous possible origins, and can be linked to auto-immune diseases, metabolic disorders (i.e. galactosemia) or even genetic abnormalities. According to her origin, POF is characterized by (a) a depletion of primary follicles, (b) increased or accelerated follicle atresia (c) an alteration of the recruitment of dominant follicle and (d) stopped follicular maturation. The purpose of our work is to organize a clinical and fundamental research network focussed on premature ovarian failure (POF). It will aim to collect clinical, biological, radiological and histological information on patients, and according to their phenotypes, to decide for searching possible genetic abnormalities leading to POF. And in the same time, the constitution of a broad tissue collection allows the study of ovarian transcripts, using POF as a pathologic model to describe ovaries and follicle development-involved genes.

Interventions

None listed

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 39 Years
Healthy volunteers
Yes

Inclusion criteria

: Experimental group: * 18 years \<Age\> 39 years * Patient with amenorrhea since at least 3 months * Patient with at least 1 FSH dosage \> 30 mUI/L * Patients between 40 and 45 years old with hormonal results indicating a POF declared before 39 years old will be included. * Informed Consent Form Signature Control group: * 18 years \<Age\> 39 years * Patient having a benign ovarian pathology justifying an ovarian surgery * Informed Consent Form Signature

Exclusion criteria

Not applicable

Countries

France

Contacts

Primary ContactPhilippe Touraine, MD, PhD
philippe.touraine@psl.aphp.fr+33 1 42 16 02 11

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026